Your browser doesn't support javascript.
loading
Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial.
Ntinginya, Nyanda Elias; Te Brake, Lindsey; Sabi, Issa; Chamba, Nyasatu; Kilonzo, Kajiru; Laizer, Sweetness; Andia-Biraro, Irene; Kibirige, Davis; Kyazze, Andrew Peter; Ninsiima, Sandra; Critchley, Julia A; Romeo, Renee; van de Maat, Josephine; Olomi, Willyhelmina; Mrema, Lucy; Magombola, David; Mwayula, Issakwisa Habakkuk; Sharples, Katrina; Hill, Philip C; van Crevel, Reinout.
Afiliação
  • Ntinginya NE; National Institute for Medical Research (NIMR), Mbeya Medical Research Centre, Mbeya, Tanzania. nelias@nimr-mmrc.org.
  • Te Brake L; Departmentt of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center (RUMC), Nijmegen, The Netherlands.
  • Sabi I; National Institute for Medical Research (NIMR), Mbeya Medical Research Centre, Mbeya, Tanzania.
  • Chamba N; The Good Samaritan Foundation (Kilimanjaro Christian Medical Centre GSF KCMC), Moshi, Tanzania.
  • Kilonzo K; Kilimanjaro Christian Medical University College, Moshi, Tanzania.
  • Laizer S; The Good Samaritan Foundation (Kilimanjaro Christian Medical Centre GSF KCMC), Moshi, Tanzania.
  • Andia-Biraro I; Kilimanjaro Christian Medical University College, Moshi, Tanzania.
  • Kibirige D; The Good Samaritan Foundation (Kilimanjaro Christian Medical Centre GSF KCMC), Moshi, Tanzania.
  • Kyazze AP; Kilimanjaro Christian Medical University College, Moshi, Tanzania.
  • Ninsiima S; Department of Internal Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Critchley JA; Uganda Martyrs Hospital Lubaga, Kampala, Uganda.
  • Romeo R; Department of Internal Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
  • van de Maat J; Department of Internal Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Olomi W; St George's University of London, London, UK.
  • Mrema L; King's College London, London, UK.
  • Magombola D; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Mwayula IH; National Institute for Medical Research (NIMR), Mbeya Medical Research Centre, Mbeya, Tanzania.
  • Sharples K; National Institute for Medical Research (NIMR), Mbeya Medical Research Centre, Mbeya, Tanzania.
  • Hill PC; National Institute for Medical Research (NIMR), Mbeya Medical Research Centre, Mbeya, Tanzania.
  • van Crevel R; Mbeya Zonal Referral Hospital (MZRH), Mbeya, Tanzania.
Trials ; 23(1): 480, 2022 Jun 10.
Article em En | MEDLINE | ID: mdl-35689272
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Diabetes Mellitus Tipo 2 / Tuberculose Latente / Isoniazida Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Diabetes Mellitus Tipo 2 / Tuberculose Latente / Isoniazida Idioma: En Ano de publicação: 2022 Tipo de documento: Article